Obesity care is at a pivotal moment. While obesity rates are at an all-time high, anti-obesity medications (AOMs) like GLP-1s offer clinicians and patients a powerful new tool. However, AOMs are not a standalone solution. For effective treatment, they must be combined with a comprehensive approach that includes physical activity, behavioral modifications, and access to nutrition therapy.
This Blueprint for Action provides practical, actionable steps that stakeholder groups—including patients, clinicians, advocates, researchers, and policymakers—should take to build the evidence, guidelines, and policies necessary for the development of comprehensive obesity care management. By implementing these solutions, we can create better outcomes and improved quality of life for millions of people living with obesity.


